title: BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics.
authors: Rheumatology Department, Norfolk and Norwich University Hospital, Norwich louise.hamilton@nnuh.nhs.uk.
authors: Louise
authors: L
authors: Hamilton
authors: Rheumatology Department, New Cross Hospital, Wolverhampton.
authors: Nick
authors: N
authors: Barkham
authors: Rheumatology Department, Royal National Hospital for Rheumatic Diseases, Bath.
authors: Ashok
authors: A
authors: Bhalla
authors: Private residence, Grantham.
authors: Robin
authors: R
authors: Brittain
authors: National Ankylosing Spondylitis Society, London, UK.
authors: Debbie
authors: D
authors: Cook
authors: Institute of Applied Health Sciences, University of Aberdeen, Aberdeen.
authors: Gareth
authors: G
authors: Jones
authors: Rheumatology Department, Torbay Hospital, Torquay.
authors: Kirsten
authors: K
authors: Mackay
authors: Rheumatology Department, Inverclyde Royal Hospital, Greenock.
authors: David
authors: D
authors: Marshall
authors: NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds.
authors: Helena
authors: H
authors: Marzo-Ortega
authors: Honiton Surgery and Rheumatology Department, Royal Devon and Exeter Hospital, Exeter.
authors: Daniel
authors: D
authors: Murphy
authors: Rheumatology Department, Musgrave Park Hospital, Belfast Health and Social Care Trust, Belfast.
authors: Claire
authors: C
authors: Riddell
authors: Rheumatology Department, Royal National Hospital for Rheumatic Diseases, Bath.
authors: Raj
authors: R
authors: Sengupta
authors: Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow.
authors: Stefan
authors: S
authors: Siebert
authors: Rheumatology Department, Kent and Canterbury Hospital, Canterbury.
authors: Liz
authors: L
authors: Van Rossen
authors: Rheumatology Department, Norfolk and Norwich University Hospital, Norwich.
authors: Karl
authors: K
authors: Gaffney
mesh_terms: D018501:Antirheumatic Agents / Q000592:standards*; D001688:Biological Products / Q000592:standards*; D006801:Humans; D025241:Spondylarthritis / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D006113:United Kingdom
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha
keywords: ankylosing spondylitis; anti-TNF; axial spondyloarthritis; biologic; guideline; treatment